Company news
Pharmacielo Ltd. (TSXV:PCLO) news
Pharmacielo Ltd. news releases on 6ix. Latest, Aug 28, 2026: PharmaCielo Announces 2026 First Quarter Results
Press releases & updates
PharmaCielo Announces 2026 First Quarter Results
August 28, 2026
PharmaCielo Announces 2026 Year-End Results
July 30, 2026
PharmaCielo Announces the Issuance of Interest Shares and Update on Insider Bridge Financing
May 19, 2026
PharmaCielo Announces Intention to Issue Interest Shares
April 17, 2026
PharmaCielo Announces the Issuance of Interest Shares
March 17, 2026
PharmaCielo Announces 2025 Q3 Results, AGM Details
March 2, 2026
PharmaCielo Announces Annual General Meeting and Intention to Issue Interest Shares
February 17, 2026
Canadian Investment Regulatory Organization Trade Resumption - PCLO
January 2, 2026
PharmaCielo Announces Revocation of FFCTO and Related Corporate Matters
December 30, 2025
PharmaCielo Completes La Margarita Land Sale, Repays Banco Agrario Loan, Strengthens Balance Sheet, Completes Audit
October 6, 2025
PharmaCielo Announces Issuance of Cease Trade Order
August 6, 2025
Canadian Investment Regulatory Organization Trading Halt - PCLO
August 6, 2025
PharmaCielo Reports Q4 2024 Financial Results
February 28, 2025
PharmaCielo Announces Issuance of Shares for Settlement of Certain Amounts Owing
February 12, 2025
PharmaCielo Reports Q3 2024 Financial Results
December 2, 2024
PharmaCielo Announces Intention to Extend Expiry Date of Warrants
November 5, 2024
PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024
October 7, 2024
PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2024
August 16, 2024
CORRECTION FROM SOURCE: PharmaCielo Provides Update on Reinstatement for Trading
July 17, 2024
PharmaCielo Provides Update on Reinstatement for Trading
July 17, 2024
PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2023, and the First Quarter Ended March 31, 2024
July 4, 2024
PharmaCielo Announces Issuance of Failure to File Cease Trade Order
May 8, 2024
PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors
April 10, 2024
PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil
March 26, 2024
Colombian Government Continues its Support of Domestic Cannabis Industry - Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo
March 1, 2024
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products
January 4, 2024
PharmaCielo Announces Q3 2023 Financial Results
November 29, 2023
PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private Placement
October 6, 2023
PharmaCielo Announces Q2 2023 Financial Results
August 29, 2023
PharmaCielo Provides Corporate Update
August 10, 2023
PharmaCielo Announces Appointment of Marc Lustig as Chairman and CEO
July 11, 2023
PharmaCielo Announces Q1 2023 Financial Results
May 29, 2023
PharmaCielo Announces Shipment of Pharmaceutical Grade Cannabis Extract to Customer in South Africa
May 16, 2023
PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2022
May 1, 2023
PharmaCielo Announces Strategic Partnership with CANNPRISMA to Supply EU-GMP Certified Dried Flower to the European Medicinal Cannabis Market
April 19, 2023
TSX Venture Exchange Stock Maintenance Bulletins
April 14, 2023
PharmaCielo Receives Purchase Order for API from Brazilian Pharmaceutical Company - Represents Third Customer in the Country
February 8, 2023
PharmaCielo Announces Continued Progress on Efficiency Initiatives to Accelerate Profitability and Intention to Amend Warrant Terms
February 2, 2023
PharmaCielo Receives First Commercial Purchase Order from Ease Labs Pharma - Proprietary API a Key Ingredient in Recently Approved Product for Brazilian Market
January 30, 2023
PharmaCielo Announces First Shipment of Pharmaceutical Grade Cannabis Extract to Customer in Morocco
December 5, 2022
PharmaCielo Announces TSX Venture Exchange Approval of Warrant Extension
November 22, 2022
PharmaCielo Announces Q3 2022 Financial Results
October 31, 2022
PharmaCielo Announces Shipment of Pharmaceutical Grade Cannabis Extract to Customer in Uruguay
October 12, 2022
PharmaCielo Announces Shipment of Dried Cannabis Flower to the Czech Republic, Representing the Company's First Shipment of Medicinal Grade Dried Cannabis Flower into the EU
September 15, 2022
PharmaCielo Announces Receipt of Production Quota of THC Dominant Dried Cannabis Flower for Export - Commercial Quantities of Flower Shipments to Begin in Early 2023
September 14, 2022
PharmaCielo Announces Q2 2022 Financial Results; Upsizes Oversubscribed Debenture Financing
August 30, 2022
PharmaCielo Announces Receipt of ICANN G.A.P and GACP Certifications, Opening Commercial Access to the Israeli Market
August 25, 2022
PharmaCielo Announces First Shipment to Mexican Joint Venture Partner
August 4, 2022
PharmaCielo Announces Sales Agreement with Brazilian Phyto-Therapeutic Customer, and Key Management and Board Appointments
July 28, 2022
PharmaCielo Announces Shipment of CBD Full Spectrum Oil to a Brazilian Pharmaceutical Customer
June 6, 2022